'Biocon looking at options to cut debt taken for Viatris' business buy'

"We are looking at a number of options to reduce that... I can say that you'll see the debt level coming down in the coming quarters," he said. Bains, who took over as group CEO of Biocon in September, declined to comment on specific debt reduction plans or timeline.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/dLUx6O5
via IFTTT